ライフサイエンスコーパス: MgSO4

1 MgSO4 infusion in patients with severe preeclampsia rest

2 were extracted with acidified ethyl acetate, MgSO4 and CH3COONa and cleaned up by dispersive SPE with

3 er, the ability of peripherally administered MgSO4 to penetrate the blood-brain barrier is limited in

4 (PEG 2000 and 6000) and salts ((NH4)2SO4 and MgSO4) at different concentrations were used.

5 the present (40 to 0 Ma), when aragonite and MgSO4 salts were the dominant marine precipitates.

6 by a primary-secondary amine (PSA), GCB, and MgSO4.

7 0 mM solutions of magnesium salts (MgCl2 and MgSO4).

8 e use of acetonitrile extraction solvent and MgSO4, PSA, C18 and Florisil as cleanup reagents was rec

9 phase separation, 1.5g NaCl and 4g anhydrous MgSO4 were added.

10 jections of suspensions of Ag-NPs in aqueous MgSO4 solutions were applied to the ceramic medium, and

11 ATP, MgSO4, KCl, and DTT, important in cell-free expansion of

12 vags are surprisingly no longer modulated by MgSO4 in the risA(-) background.

13 lating strains by growth on media containing MgSO4 does not affect virulence in the mouse aerosol cha

14 he MgSO4 bolus (4 g), followed by continuous MgSO4 infusion (1 g/h).

15 In MgSO4 droplets, water diffusivity decreases sharply with

16 ification of crystalline water in kieserite (MgSO4.H2O) is linked to materials exposed in a valley an

17 ion followed the UNE-EN 15662 method (150 mg MgSO4, 25mg primary secondary amines and 25mg of octadec

18 ,N'-bis(2-ethanesulfonic acid) (Pipes), 1 mM MgSO4, and 2 mM [ethylenebis(oxyethylenenitrilo)]tetraac

19 .1 M Pipes buffer (1 mM GTP, 1 mM EGTA, 1 mM MgSO4, pH 6.4).

20 n increased when cells were starved in 10 mM MgSO4 and when they were grown in conditioned medium in

21 delity was highest in the presence of 2-3 mM MgSO4 and 100-300 microM each dNTP and at pH 8.5-9.1.

22 Ka for the purple-to-blue transition in 5 mM MgSO4.

23 tional 2 protons with a pKa of 2.75, in 5 mM MgSO4.

24 wed by phase separation with the addition of MgSO4:NaCl.

25 jury and limits the brain bioavailability of MgSO4.

26 Mg2+ which consisted of an initial bolus of MgSO4 (600 mg/kg, i.p.) 1 h prior to hypoxia followed by

27 Infusion of MgSO4 in severe preeclamptic patients.

28 vaporative conditions and in the presence of MgSO4 , the UAFW eutectic mobilizes the phosphate seques

29 binant HIV-1 IN at pH 6.8 in the presence of MgSO4 that performed full-site integration nearly as eff

30 Despite widespread use of MgSO4 in clinical practice, its effects on adult offspri

31 ignals; significantly more nicotinic acid or MgSO4 was required to modulate the chimeric strain compa

32 flammation and the effectiveness of prenatal MgSO4/betamethasone treatments between males and females

33 eclinical investigations, magnesium sulfate (MgSO4) has gained interest as a neuroprotective agent.

34 acid) and inorganic gels (magnesium sulfate, MgSO4).

35 ch as betamethasone) and magnesium sulphate (MgSO4) are administered to women in preterm labor to red

36 ne, 5 minutes, 1 hour, and 6 hours after the MgSO4 bolus (4 g), followed by continuous MgSO4 infusion

37 Five minutes after the MgSO4 bolus infusion, a median increase of 8.6% (3.2-18.

38 significantly decreased (p < 0.01) after the MgSO4 bolus, whereas cardiac output did not change.

39 Because phases in the MgSO4*nH2O system are sensitive to temperature and humid

40 hydrates likely to be present, those of the MgSO4*nH2O series have many hydration states.

41 llowed by salt-out liquid partitioning using MgSO4, NaCl, and citrate buffer salts.

42 method and a subsequent d-SPE cleaning with MgSO4 and C18 were used for samples preparation.

43 Tofu was coagulated with MgSO4.

44 In modulating conditions, with MgSO4, the BvgA/S system is inactive, and the vrgs are e

45 up by dispersive solid-phase extraction with MgSO4, PSA, C18, and alumina-neutral.

46 The animals were treated intravenously with MgSO4 (2 g bolus x 20 minutes followed by 2 g/h infusion

47 Prenatal treatment with MgSO4/betamethasone confers long-term benefits beyond ce